The ACMG 59 report focuses on assessing your core health genes as recommended by the American College of Medical Genetics and Genomics (ACMG). The report examines the 59 genes defined by ACMG for their clinically important variants ranging from breast-ovarian cancer to lynch syndrome to malignant hyperthermia.
The ACMG 59 Report helps guide patients and doctors to better preventive care and medicine by providing actionable genetic findings that encompass pathogenic or potentially pathogenic variants. Children and adults having disease-related markers can proactively approach healthcare providers for appropriate diagnoses.
- Included features:
- Primary and Secondary Findings
- Gene names, variants, positions, and zygosities
- Clinical classification of disease-related markers
Requires physician’s approval and patient’s consent. Please consult with your healthcare provider for more information.